Abbvie Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Abbvie Inc with three other companies in this sector in UNITED STATES : Bristol-Myers Squibb Company (2020 sales of $42.52 billion of which 28% was Prioritized Brands-Revlimid), Pfizer Inc. ($41.91 billion of which 26% was Oncology), and Merck & Co. , Inc. ($47.99 billion of which 90% was Merck Pharmaceutical).

Sales Analysis. During the year ended December of 2020, sales at Abbvie Inc were $45.80 billion. This is an increase of 37.7% versus 2019, when the company's sales were $33.27 billion. This was the fifth consecutive year of sales increases at Abbvie Inc (and since 2015, sales have increased a total of 100%).